NCT02861534 A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001) Status COMPLETED Phase PHASE3
NCT02857478 Supervised Outdoor-Use Test to Assess the Safety of a Sunscreen C-Spray on Sport Users Status COMPLETED Phase NA
NCT02854137 Evaluation of the Irritation Potential of Sunscreen Products in Human Eyes Status COMPLETED Phase NA
NCT02850263 A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema Status COMPLETED Phase N/A
NCT02846532 Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure Status COMPLETED Phase PHASE3
NCT02842268 Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating Status COMPLETED Phase NA
NCT02840903 A Non-interventional Study to Observe the Computed Tomographic Angiography Image Quality With Different Contrast Media Injection Protocols Under Different Computed Tomography Machines Parameters Setting Status COMPLETED Phase N/A
NCT02835924 Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC Status COMPLETED Phase PHASE2
NCT02833948 Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT) Status COMPLETED Phase PHASE3
NCT02832544 INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority Status COMPLETED Phase PHASE3
NCT02831478 Outdoor-Use Test for Sunscreen Products in Children Ages 3 to 9 Years Old Status COMPLETED Phase NA
NCT02830477 Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis Status COMPLETED Phase N/A
NCT02826252 Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20) Status COMPLETED Phase N/A
NCT02825160 Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH) Status COMPLETED Phase N/A
NCT02824042 Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole Status COMPLETED Phase PHASE1